The Management Team

Habib Torfi Founder, Chairman and CEO.  Before founding Invitrx in Irvine, CA back in 2003; he directed the Laboratory of Regenerative Bioengineering and Repair for the Department of Surgery at UCLA from 1998-2001. The laboratory goal was discovering and developing proprietary, cell-based therapeutics utilizing adult stem cells derived from adipose tissue. Mr. Torfi was the director of Epithelial Autograft Facility at UC Davis Medical Center in Sacramento, California. Epithelial Autograft Facility provided three dimensional tissue engineered skin and cornea for burn, diabetic leg ulcer and patients with ocular surface disorders. Mr. Torfi holds an Undergraduate degree in Microbiology and a graduate degree in Human genetics. He is licensed as a clinical scientist in state of California. Mr. Torfi has published numerous papers and holds several patents in stem cell and bioengineering field.

Shahrokh Zekavati, PhD, R&D and Operation Director of Cosmetic Department. Shahrokh joined Invitrx Therapeutic with 30 years of cosmetic and pharmaceuticalindustry experience and a strong educational background. He earned his Doctorate of Engineering and Master of Science in Physical Organic Chemistry from the University of Science and Technology at Languedoc – Montpellier (France). He also earned another Master of Science and Bachelor of Science in Chemical Engineering from Tehran University (Iran). He is one of the primary developers of Invitrx Product Line and is continuously contributing to scientific research and product development. With his knowledge and experience in formulation and operation, Shahrokh operates as a liaison between Invitrx and new product requests.

Ki-Young Sohn, Finance and Business Consultant. Oversees all investment and business development activities within FAS Holdings as chairman and founder. His major focus and direct involvement is the execution of all financial programs.